Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Current Leases (2020 - 2026)

Journey Medical filings provide 6 years of Current Leases readings, the most recent being $101000.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 21.69% to $101000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $101000.0, a 21.69% increase, with the full-year FY2025 number at $101000.0, up 21.69% from a year prior.
  • Current Leases hit $101000.0 in Q4 2025 for Journey Medical, up from $98000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $101000.0 in Q4 2025 to a low of $25000.0 in Q3 2022.
  • Median Current Leases over the past 5 years was $93000.0 (2023), compared with a mean of $80944.4.
  • Biggest five-year swings in Current Leases: crashed 73.96% in 2022 and later surged 288.0% in 2023.
  • Journey Medical's Current Leases stood at $98000.0 in 2021, then decreased by 15.31% to $83000.0 in 2022, then increased by 19.28% to $99000.0 in 2023, then dropped by 16.16% to $83000.0 in 2024, then rose by 21.69% to $101000.0 in 2025.
  • The last three reported values for Current Leases were $101000.0 (Q4 2025), $98000.0 (Q3 2025), and $96000.0 (Q2 2025) per Business Quant data.